Improved understanding of appetite-control proteins suggest treatment of obesity

March 26, 2014
Improved understanding of appetite-control proteins suggest treatment of obesity
Found in the brain, the MeCP2 protein plays a crucial role in the control of hormones that regulate appetite and metabolism. Deletion of MeCP2 may increase cravings for fatty foods and lead to obesity. Credit: leolintang/iStock/Thinkstock

The main cause of weight gain, and ultimately obesity, is an energy imbalance in the body triggered by increased food intake, often coupled with reduced energy expenditure. Two hormones called leptin and α-MSH (α-melanocyte-stimulating hormone) regulate the so-called 'energy homeostasis' in the body by influencing the brain to control appetite, metabolism and behavior.

The hormone acts on at least two sets of in the brain, including a group called the pro-opiomelanocortin (POMC) neurons. Scientists know that impaired POMC regulation leads to leptin resistance and obesity, but are unclear about the exact mechanism by which this occurs.

Now, Weiping Han and colleagues at the A*STAR Singapore Bioimaging Consortium and Institute of Molecular and Cell Biology, together with co-workers from Hungary and the United States, have shown that deleting a protein called methyl-CpG-binding protein 2 (MeCP2) can promote weight gain and obesity in mice.

The team previously investigated the onset of leptin resistance during a high fat diet. "We examined whether epigenetic changes, such as DNA methylation, could alter the gene expression of the critical regulators of energy homeostasis," notes Han. "POMC neurons are regulated by MeCP2, so we chose to investigate what would happen if this relationship was disrupted."

The team bred genetically altered mice that had MeCP2 deleted specifically in the POMC neurons in the hypothalamus region of the brain. Their growth and feeding behavior on a were then compared to their littermate control group with fully functioning MeCP2. After eight months, the MeCP2-knockout mice showed higher levels of leptin circulating in the blood, alongside increased body weight and fat levels.

Under normal physiological conditions, MeCP2, along with other factors, allows increased expression of POMC. "This occurs in response to cues from hormones such as leptin," explains Han. "POMC is then processed to generate α-MSH, which is released from POMC neurons to control appetite and feeding behavior."

The researchers found that without MeCP2 to increase POMC expression in response to rising , not enough α-MSH was released to stem the appetite. This led to all of the MeCP2-knockout mice becoming overweight.

"Knowing that increased DNA methylation in POMC promoters may lead to leptin resistance and provides new options for weight management," states Han. "Targeting epigenetic modification and regulation might be a viable approach to treat obesity."

Hoping to better understand the onset of obesity, the team is now researching other proteins that might affect the neurons and hormonal pathways in the brain.

Explore further: Voluntary exercise by animals prevents weight gain, despite high-fat diet

More information: Wang, X., Lacza, Z., Sun, Y. E. & Han, W. "Leptin resistance and obesity in mice with deletion of methyl-CpG-binding protein 2 (MeCP2) in hypothalamic pro-opiomelanocortin (POMC) neurons." Diabetologia 57, 236–245 (2014). dx.doi.org/10.1007/s00125-013-3072-0

Related Stories

Obesity: How inflammation influences appetite

June 5, 2013

Sustained low-grade inflammation and an above-average appetite are commonly found in obese individuals. Therefore, it seems counterintuitive that the acute inflammation associated with many illnesses normally suppresses appetite. ...

Recommended for you

Do germs cause type 1 diabetes?

May 16, 2016

Germs could play a role in the development of type 1 diabetes by triggering the body's immune system to destroy the cells that produce insulin, new research suggests.

New gene for familial high cholesterol

May 12, 2016

New research from Denmark reveals the gene that explains one quarter of all familial hypercholesterolemia with very high blood cholesterol. Familial hypercholesterolemia is the most common genetic disorder leading to premature ...

Melatonin signaling is a risk factor for type 2 diabetes

May 12, 2016

A sleeping pancreas releases less insulin, but how much insulin drops each night may differ from person to person, suggests a study published May 12, 2016 in Cell Metabolism. Up to 30 percent of the population may be predisposed ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.